Literature DB >> 10644075

Application of supercritical carbon dioxide for the preparation of a piroxicam-beta-cyclodextrin inclusion compound.

T Van Hees1, G Piel, B Evrard, X Otte, L Thunus, L Delattre.   

Abstract

PURPOSE: Piroxicam is a poorly soluble NSAID, whose solubility is enhanced when included into beta-cyclodextrin. The preparation of a piroxicam-beta-cyclodextrin inclusion compound using supercritical CO2 was investigated.
METHODS: The solubility and the stability of piroxicam in supercritical CO2 were determined. Then, the influence of the temperature, the pressure and the time of exposure on the inclusion rate was studied.
RESULTS: The solubility of piroxicam varied over a wide range depending on the temperature and pressure (from 0.006 to 1.500 mg/g of CO2). The temperature and the time of exposure had a great influence on the inclusion yield, while pressure did not and a complete inclusion was achieved by keeping a physical mixture of piroxicam and beta-cyclodextrin (1:2.5 mol/mol) for 6 hours at 150 degrees C and 15 MPa of CO2. This complex was characterized by Differential Scanning Calorimetry, differential solubility and Fourier Transform Infrared Spectrometry.
CONCLUSIONS: Supercritical carbon dioxide may prove to be a novel useful complexation method of drugs into beta-cyclodextrin.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10644075     DOI: 10.1023/a:1018955410414

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  4 in total

1.  Inclusion compounds of non-steroidal antiinflammatory and other slightly water soluble drugs with alpha- and beta-cyclodextrins in powdered form.

Authors:  M Kurozumi; N Nambu; T Nagai
Journal:  Chem Pharm Bull (Tokyo)       Date:  1975-12       Impact factor: 1.645

2.  Oral bioavailability of CHF1194, an inclusion complex of piroxicam and beta-cyclodextrin, in healthy subjects under single dose and steady-state conditions.

Authors:  X Deroubaix; A Stockis; A M Allemon; E Lebacq; D Acerbi; P Ventura
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

3.  Macrocyclic molecules and their pharmacological applications.

Authors:  L Lasagna
Journal:  Eur J Rheumatol Inflamm       Date:  1993

4.  Supermolecular inclusion of piroxicam with beta-cyclodextrin: pharmacokinetic properties in man.

Authors:  B G Woodcock; D Acerbi; P G Merz; S Rietbrock; N Rietbrock
Journal:  Eur J Rheumatol Inflamm       Date:  1993
  4 in total
  9 in total

1.  Oral bioavailability in pigs of a miconazole/hydroxypropyl-gamma-cyclodextrin/L-tartaric acid inclusion complex produced by supercritical carbon dioxide processing.

Authors:  Valéry Barillaro; Brigitte Evrard; Luc Delattre; Géraldine Piell
Journal:  AAPS J       Date:  2005-08-18       Impact factor: 4.009

2.  Comparative evaluation of ibuprofen/beta-cyclodextrin complexes obtained by supercritical carbon dioxide and other conventional methods.

Authors:  Khaled Hussein; Michael Türk; Martin A Wahl
Journal:  Pharm Res       Date:  2007-03       Impact factor: 4.200

3.  Preparation of budesonide and budesonide-PLA microparticles using supercritical fluid precipitation technology.

Authors:  Todd M Martin; Nagesh Bandi; Ryan Shulz; Christopher B Roberts; Uday B Kompella
Journal:  AAPS PharmSciTech       Date:  2002       Impact factor: 3.246

4.  Piroxicam Loading onto Mesoporous Silicas by Supercritical CO2 Impregnation.

Authors:  Marta Gallo; Luca Serpella; Federica Leone; Luigi Manna; Mauro Banchero; Silvia Ronchetti; Barbara Onida
Journal:  Molecules       Date:  2021-04-25       Impact factor: 4.411

5.  Crystal structure changes of gamma-cyclodextrin after the SEDS process in supercritical carbon dioxide affect the dissolution rate of complexed budesonide.

Authors:  Tarja Toropainen; Teemu Heikkilä; Jukka Leppänen; Laura Matilainen; Sitaram Velaga; Pekka Jarho; Johan Carlfors; Vesa-Pekka Lehto; Tomi Järvinen; Kristiina Järvinen
Journal:  Pharm Res       Date:  2007-03-24       Impact factor: 4.580

Review 6.  Supercritical Fluid Technology: An Emphasis on Drug Delivery and Related Biomedical Applications.

Authors:  Ranjith Kumar Kankala; Yu Shrike Zhang; Shi-Bin Wang; Chia-Hung Lee; Ai-Zheng Chen
Journal:  Adv Healthc Mater       Date:  2017-07-28       Impact factor: 9.933

Review 7.  Supercritical Carbon Dioxide as a Green Alternative to Achieve Drug Complexation with Cyclodextrins.

Authors:  Mauro Banchero
Journal:  Pharmaceuticals (Basel)       Date:  2021-06-11

Review 8.  Piroxicam-β-cyclodextrin: a GI safer piroxicam.

Authors:  C Scarpignato
Journal:  Curr Med Chem       Date:  2013       Impact factor: 4.530

9.  Hydroxypropyl-β-cyclodextrin for Delivery of Baicalin via Inclusion Complexation by Supercritical Fluid Encapsulation.

Authors:  Ying Li; Zhen-Dan He; Qian-En Zheng; Chengshen Hu; Wing-Fu Lai
Journal:  Molecules       Date:  2018-05-14       Impact factor: 4.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.